Business strategy


Agile. International. High-performing.

Every year we strive to improve therapies by reliably supplying millions of doses of our products across a wide range of therapeutic classes.

In the rest of the world, we deliver our top products through a consolidated network of strategic international & local partners.

We currently market over 250 products globally, with an active pipeline of new ones always on the way. We have adopted two different business models to manage daily challenges and leverage opportunities for growth. In Switzerland, Germany, Austria and the USA our specialized national teams directly sell, promote and market our products. In the United States, while having established our direct business, we also leverage on strategic partnerships.

Management
team


United by the commitment to improving therapies and satisfying patients’ needs, our executive team will guide Sintetica into the future of global healthcare.

Hubert Puech d’Alissac
Executive Chairman of the Board

Sameer Agarwal
Board Member and
Chief Commercial Officer

Luca Casella
Chief Financial Officer

Sergio Cantoreggi
Chief Scientific Officer

Mirco Montella
Chief Innovation Officer and
Deputy Commercial Officer

Daniele Fontana
Sustainability & HR Director


Business
Development

We offer a dynamic portfolio of selected branded and generic products, developed to address certain niche and unmet clinical needs. We strive to build strong and long-lasting successful alliances with our international partners.

Business Development Sintetica

Business
Overview

Sintetica is a fast-growing specialty pharma company fully integrated from R&D and production to distribution. While having established our direct business, we also leverage on strategic partnerships.

Business Overview Sintetica

Value Proposition


All our medicines are manufactured and controlled under strict quality and safety measures, meeting the highest Swiss, European, US and international standards. Sintetica boasts a state-of-the-art, FDA-approved production facility in Switzerland with low saturation and best-in-class manufacturing know-how.

Sintetica delivers its distinctive Value Proposition through:

⎯⎯ Privileged connection to all Swiss hospitals

⎯⎯ Continuous innovation based on deep understanding of medical needs

⎯⎯ Excellent inroads into key markets of Germany, Austria and the USA

⎯⎯ Quality without compromises on the entire production

⎯⎯ An agile and empowered organization founded on responsibility and merit

⎯⎯ Strategic partnerships along the whole Value Chain based on shared values

⎯⎯ Well established global network of partners in multiple markets across the globe

⎯⎯ Top Quality products manufactured in Switzerland

⎯⎯ Consistency in supply thanks to flexible manufacturing and short supply chain